logo
'Meant to be': Oklahoma cardiologist treats man's heart attack symptoms mid-flight

'Meant to be': Oklahoma cardiologist treats man's heart attack symptoms mid-flight

Yahoo31-05-2025
An Oklahoma cardiologist had a full circle moment when a Dutch man complained of chest pains on their shared flight.
Dr. TJ Trad, a cardiologist at Stillwater Medical Center and founder of the nonprofit Cura for the World Foundation, was traveling home from a medical mission trip in Uganda when he was awoken on the flight to Amsterdam, CNN reported. A man was complaining of chest pain and needed a doctor, he was told by a nurse on his team.
Trad found the man drenched in sweat, and he asked the doctor, "Am I going to die?"
"Not today," Trad told him before getting to work.
Trad had the medications needed to treat a heart attack on hand — including nitroglycerin, Aspirin, Plavix, metoprolol and lisinopril — part of the around two dozen medications he carries with him on medical mission in case anyone on his team has an emergency.
But Trad, 43, also had a pocket-sized electrocardiogram, which he carries with him since having his own heart scare last year.
One February morning in 2024, just days before he was scheduled to fly to Uganda for a planned medical mission trip, Trad said he was doing a procedure on a patient when he began having chest pain. He was experiencing an 80% blockage in one of his arteries — he had a stent placed that same day and canceled his trip to Uganda.
As a way to mark the one year anniversary of his cardiac scare, Trad finished the climb to Everest Base Camp at the beginning of March.
"I believe that everything happens for a reason, as cliche as that might sound," Trad said. "Maybe the event that occurred a year ago was the nidus for me to be on that specific plane to help that specific person. Every time, let's say something negative or positive happens, it's good to kind of sit back and reflect on what's the downstream effect of that? So yeah, I feel like we were meant to be on that flight to help."
Not only does Trad believe he was meant to be on the flight to help the Dutch man, but he has the same sense regarding the trip to Uganda. While on their trip, Trad met an 8-month-old girl with a 7.8 millimeter ventricular septal defect.
The funds have already been raised to cover her heart surgery, which should be taking place soon, he said.
"What are the chances that a cardiologist would appear at that specific time in her life ... it's one of those things," Trad said. "It's not a coincidence."
The man on the plane told Trad his chest pain, on a scale of 1 to 10, was a 10. It was a pain Trad had warned his patients about, but also one he had felt himself.
About 15 minutes after Trad gave him medication, the man's chest pain was gone. But the doctor and nurse continually monitored his symptoms, checking his heart rhythm every five to 10 minutes for the duration of the flight.
"After his symptoms subsided, I told the pilot, 'We bought time to get to Amsterdam so that he can go to the hospital there,'" Trad said.
CNN reported that the man was examined for 12 hours at the hospital and was not diagnosed with a heart attack, stroke or pulmonary embolism — possibly as a result of Trad's treatment of the patient.
Before going their separate ways, the man's wife told Trad, "You're our angel in the sky."
This article originally appeared on Oklahoman: Oklahoma doctor treats heart attack symptoms on flight home from Uganda
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hulk Hogan's Cause of Death Exposed Alongside Hidden Health Battles
Hulk Hogan's Cause of Death Exposed Alongside Hidden Health Battles

Yahoo

time42 minutes ago

  • Yahoo

Hulk Hogan's Cause of Death Exposed Alongside Hidden Health Battles

Hulk Hogan's Cause of Death Exposed Alongside Hidden Health Battles originally appeared on Men's Fitness. Hulk Hogan's official cause of death has been revealed, as reported by Page Six. Hogan died on July 24 at 71 years old. Reports stated that he had suffered from cardiac arrest at his home in Clearwater, Florida. The outlet confirmed Hogan's cause of death was acute myocardial infarction—a heart attack—which happens when blood flow to the heart is suddenly blocked, leading to damage of the heart tissue. His death was classified as natural, according to a cremation summary approval report released by the Pinellas County Forensic Science Center. "I am not aware when Mr. Bollea will be cremated, only that we received a request for cremation approval," a spokesperson for the medical examiner's office said. Hogan had a medical history that included atrial fibrillation, a condition that causes the heart to beat irregularly and often too quickly. He had also been diagnosed with chronic lymphocytic leukemia, a type of cancer that targets white blood cells called lymphocytes—a detail that doesn't appear to have been publicly a month before his death, Hogan had undergone major spinal fusion surgery, causing the public to speculate about the wrestling legend's health status. Concerns grew after radio host Bubba the Love Sponge claimed a source told him the wrestling legend was bedridden and struggling to speak due to tracheal damage. His wife denied the rumors at the time. "His heart is strong, and there was never any lack of oxygen or brain damage. None of those rumors are true," she wrote on social media. Tributes have been pouring in for Hogan since his passing, with fans, fellow wrestlers, and celebrities honoring his Hogan's Cause of Death Exposed Alongside Hidden Health Battles first appeared on Men's Fitness on Jul 31, 2025 This story was originally reported by Men's Fitness on Jul 31, 2025, where it first appeared.

European TICC leader Normec Enters US with Three Strategic Acquisitions
European TICC leader Normec Enters US with Three Strategic Acquisitions

Yahoo

time8 hours ago

  • Yahoo

European TICC leader Normec Enters US with Three Strategic Acquisitions

Three acquisitions in Foodcare, Sustainability and Healthcare more than double Normec's addressable market. Marks entry into a fifth new geography since 2020 for the Group, which reached a valuation of over €2bn in 2024. The US TICC market is the largest globally and remains highly fragmented, presenting attractive opportunities for further consolidation. AMSTERDAM & NEW YORK, August 06, 2025--(BUSINESS WIRE)--Normec ("the Group"), a leading European provider of Testing, Inspection, Certification, and Compliance ("TICC") services, today announces its entry into the United States ("US") through the acquisition of three highly specialized companies in the Foodcare, Sustainability, and Healthcare sectors. Normec is backed by Astorg, a leading pan-European private equity firm, and the majority shareholder in the Group since 2020. Headquartered in Amsterdam, Normec enables organisations to innovate safely, quickly and cost-efficiently across the TICC industry, which is a €200bn global market. Today's announcement sees Normec enter the US, which has the largest TICC market worldwide. These acquisitions more than double Normec's addressable market and reinforce its position as a leading international specialist TICC platform with deep expertise across its four highly regulated and fast-growing end markets, including food, life safety, sustainability and healthcare. Entering the US TICC market represents the fifth successful entry into a new geography by Normec in the last five years and the continued execution of Normec's growth strategy. The US is a highly fragmented TICC market and presents attractive opportunities for further consolidation. Normec has completed 85+ acquisitions in total. The acquired companies include: MS Bio (Founded in 2018 in Champaign, Illinois): A nutrition supplement focused testing lab, serving manufacturers and producers in the dietary supplement, functional food and cosmetics industries, through microbiological and several other testing methods. MJ Reider (Established in 1952 near Philadelphia, Pennsylvania): A full-service water testing laboratory offering comprehensive analyses across microbiology, inorganic and organic compounds, PFAS, and dioxins. NorthEast BioLab (Founded in 2003 in Hamden, Connecticut): A CLIA certified bioanalytical laboratory supporting the biopharmaceutical sector across all stages of drug development from discovery to clinical trials. Clients span biotech firms, pharmaceutical companies, research institutions, and contract research organizations (CROs). The specialized capabilities of these labs deepen Normec's expertise across bioanalysis, water quality, and nutritional testing, reinforcing its role in its four end markets. Normec now serves clients across Europe and North America, strengthening its mission to deliver best-in-class compliance services in complex, regulated environments as a global and specialized sector-driven compliance leader. Joep Bruins, CEO of Normec, said: "Today's announcement marks a pivotal moment in Normec's journey and more than doubles our addressable market. With a Group valuation now exceeding €2bn, the addition of these three businesses, each known for deep technical expertise, customer trust, and unwavering commitment to quality, provide a strong foothold in the world's largest TICC market. We see a significant opportunity to continue to grow both organically and inorganically across the US and internationally as we continue to execute on our growth strategy." Benjamin Cordonnier, Co-Managing Partner & CEO of Astorg, added: "We are proud to partner with Normec since 2020 and to support the Group's strong growth. Normec has successfully entered five new markets in the last five years and has completed over 85 acquisitions since 2016. Entering the US is a landmark milestone in the Group's evolution into a global TICC platform and the next step in the mission to deliver a specialized approach to compliance, operational excellence and sector depth globally." These acquisitions mark the beginning of Normec's North American journey, enabling the Group to better support clients with local expertise, trusted partnerships, and high-quality compliance solutions across critical industries. About Normec Normec, established in 2016, is a pivotal player in the Testing, Inspection, Certification, and Compliance (TICC) industry across Western Europe. By specializing in these areas, Normec enables organizations to innovate safely, quickly, and cost-efficiently. Having grown rapidly, Normec has become the quality and safety specialist, currently employing 6,000 staff across 160 locations, with 85+ completed acquisitions in over 6 countries, and operating in 4 divisions. Normec remains committed to continuing its ambitious growth trajectory, driven by organic expansion and strategic acquisitions. Balancing the demands of a rapidly evolving global landscape with the needs of its clients, Normec fosters partnerships that extend beyond the conventional, ensuring every project contributes positively towards a shared future. For more information, visit Follow Normec on Linkedin. About Astorg Astorg is a leading pan-European private equity firm with over €23 billion of assets under management. Astorg works with entrepreneurs and management teams to acquire market leading international companies headquartered in Europe or the US, providing them with the strategic guidance, governance and capital they need to achieve their growth goals. Enjoying a distinct entrepreneurial culture, a long-term shareholder perspective and a lean decision making body, Astorg has valuable industry expertise in healthcare, technology & software, and business services companies. Headquartered in Luxembourg, Astorg has offices in London, Paris, New York, Frankfurt and Milan. For more information about Astorg: | Follow Astorg on LinkedIn. View source version on Contacts Normec Anouk Wouda, Corporate Communications +31 62 83 40 468Niels Langereis, Director of Marketing & +31 63 19 14 529Astorg Samia Hadj, Head of Corporate Communicationsshadj@ +33 7 88 34 43 99Prosek Partners pro-astorg@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Holiday roulette? Boss of world's richest travel firm proposes lottery to tackle overtourism
Holiday roulette? Boss of world's richest travel firm proposes lottery to tackle overtourism

Yahoo

time9 hours ago

  • Yahoo

Holiday roulette? Boss of world's richest travel firm proposes lottery to tackle overtourism

The chief executive of the world's richest travel firm, Booking Holdings, has proposed a lottery system to tackle overtourism. Glenn Fogel, chief executive of parent company, told the BBC Today programme this morning (6 August) that visitor numbers to key destinations could be limited by a combination of 'higher cost and lottery'. Residents of some key tourism 'honeypots' across Europe, including Amsterdam, Barcelona, Dubrovnik and Venice, say that current visitors numbers are unsustainable and are damaging the community. Venice imposes a visitor levy on certain days, and there have been calls to increase it to €100 (£87). Meanwhile, authorities in Amsterdam are raising accommodation taxes. Demonstrations against excessive tourism have taken place, with some protesters in Barcelona squirting visitors with water pistols. Mr Fogel said: 'You know I heard from somebody who was in Barcelona and was squirted with a water pistol thing and they actually enjoyed it tremendously – it was so hot, they thought it was so fun. 'I'm not sure that was the intention of what they [the protesters] were trying to get across.' 'We are one stakeholder among many and we give our opinion and we absolutely want to work with government to come up with solutions. 'But at the end of the day it's not for one company to make their own decisions about how they should or should not allow people to travel or not travel. That's why we have democracy and governments – to come up with these methods to do this. 'It's not for us to try to steer somebody somewhere. That's not my job. My job's not to propagandise and try and force somebody to go someplace else. Look, somebody wants to come to London because that's their dream of their lifetime to visit London – let's face it, you haven't lived if you haven't been to London. 'Who am I to say to try and tell them, 'No no no. You don't get to go to London, You only get to go to Birmingham.' At this point the business presenter, Will Bain, intervened to say: 'I'm from Birmingham.' Mr Fogel said: 'Birmingham's a nice place. I've been there. I'm just saying, [if] someone is coming from far away, I'm not the person to make that decision for them. 'I like the idea of both higher cost and lottery, so it's not just restricted only to the elite to visit London. I think that would be a bad thing for the world. 'I think that even though you may not be wealthy, you should still get a chance to visit some of those beautiful and great places in the world.' Lotteries are used at a small scale to limit visitor numbers, primarily to US National Parks. For example, each year 450 permits are granted for rafting through the Grand Canyon on the Colorado River. At a hikers' refuge in the Arizona park, Phantom Ranch, bed spaces are allocated by lottery 15 months in advance. Justin Francis, chief executive of the environmentally-focused agency Responsible Travel, said: 'We all want tourism to be accessible to all, including those on a lower budget who could be priced out. Lotteries are already used in US National Parks, cultural events in Japan, some Antarctica expeditions, and events like Glastonbury. I think there is a place for them. 'I'm reminded of how King Charles ran a system for visits to Highgrove, you had to apply through gardening clubs – which meant that those who were able to visit had a real interest, plus gardening club memberships increased. I'd like to see disadvantaged groups get some extra chance in any lottery, and this type of approach could be used.' Mr Frances also hit out at the Booking Holdings boss, saying: 'Glenn Fogel doesn't seem overly concerned about the impacts of overtourism on residents and tourists in a growing number of destinations. He has little at stake in any destination, and his view it that if his customers want to go somewhere else they can. 'If I was his customer or a destination manager I'd expect more from the world's richest travel company.' Booking Holdings, based in Amsterdam, has a market capitalisation (the total value of its shares) of $177bn (£133bn). That makes it worth more than five times as much as Europe's biggest budget airline, Ryanair.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store